SKI Market

A+| A| A-|

Indian Indices

Sensex

77,409.98 254.36
( 0.33%)

Global Indices

Nasdaq

51,515.27 -505.40
(-0.97%)

Dow Jones

7,441.22 -91.13
(-1.21%)

Hang Seng

71,050.31 1,148.06
(1.64%)

Nikkei 225

10,505.62 11.41
(0.11%)

Forex

USD-INR

94.55 -0.09
(-0.09%)

EUR-INR

109.66 -0.13
(-0.12%)

GBP-INR

126.84 -0.25
(-0.20%)

JPY-INR

0.59 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Mercury Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

538964

INE947G01011

484

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

17.59

90.07

EPS(TTM)

Face Value()

Div & Yield %

42.68

0.47

Back

Sawaca Enterprises standalone net profit declines 32.79% in the December 2025 quarter

Feb 14,2026

Net profit of Sawaca Enterprises declined 32.79% to Rs 0.41 crore in the quarter ended December 2025 as against Rs 0.61 crore during the previous quarter ended December 2024. Sales declined 53.52% to Rs 11.43 crore in the quarter ended December 2025 as against Rs 24.59 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	11.43	24.59	-54
OPM %	-0.44	1.42	-
PBDT	0.60	0.87	-31
PBT	0.54	0.82	-34
NP	0.41	0.61	-33

77,409.98 254.36 ( 0.33%)

51,515.27 -505.40 (-0.97%)

7,441.22 -91.13 (-1.21%)

71,050.31 1,148.06 (1.64%)

10,505.62 11.41 (0.11%)

94.55 -0.09 (-0.09%)

109.66 -0.13 (-0.12%)

126.84 -0.25 (-0.20%)

0.59 0.00 (-0.20%)